nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Four-Arm, Randomized, Multicenter Phase II Trial of Oxaliplatin Combined with Varying Schedules of 5-Fluorouracil as First-line Therapy in Previously Untreated Advanced Colorectal Cancer
|
Ramanathan, Ramesh K. |
|
2008 |
7 |
2 |
p. 134-139 6 p. |
artikel |
2 |
Cetuximab plus XELIRI or XELOX for First-Line Therapy of Metastatic Colorectal Cancer
|
Moosmann, Nicolas |
|
2008 |
7 |
2 |
p. 110-117 8 p. |
artikel |
3 |
Colorectal Cancer Awareness Month
|
Chu, Edward |
|
2008 |
7 |
2 |
p. 82- 1 p. |
artikel |
4 |
Community Compliance with Carcinoembryonic Antigen: Follow-up of Patients with Colorectal Cancer
|
Spratlin, Jennifer L. |
|
2008 |
7 |
2 |
p. 118-125 8 p. |
artikel |
5 |
Correlation Between Rash and a Positive Drug Response Associated with Bevacizumab in a Patient with Advanced Colorectal Cancer
|
Saif, M. Wasif |
|
2008 |
7 |
2 |
p. 144-148 5 p. |
artikel |
6 |
Current Questions in the Treatment of Advanced Colorectal Cancer: The CAIRO Studies of the Dutch Colorectal Cancer Group
|
Simkens, Lieke |
|
2008 |
7 |
2 |
p. 105-109 5 p. |
artikel |
7 |
Evaluation of Quality of Life in Patients with Metastatic Colorectal Cancer Treated with Capecitabine
|
Segalla, José G.M. |
|
2008 |
7 |
2 |
p. 126-133 8 p. |
artikel |
8 |
Highlights from: The 2008 Gastrointestinal Cancers Symposium; Orlando, FL; January 25-27, 2008
|
Grothey, Erin |
|
2008 |
7 |
2 |
p. 86-91 6 p. |
artikel |
9 |
Pathologic Complete Response to Neoadjuvant FOLFOX in Combination with Bevacizumab in Unresectable Metastatic Colorectal Carcinoma
|
Duffy, Austin |
|
2008 |
7 |
2 |
p. 140-143 4 p. |
artikel |
10 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2008 |
7 |
2 |
p. 149- 1 p. |
artikel |
11 |
Stem Cells in Colon Cancer
|
Pohl, Alexandra |
|
2008 |
7 |
2 |
p. 92-98 7 p. |
artikel |
12 |
The Use of Capecitabine in the Combined-Modality Therapy for Rectal Cancer
|
Liauw, Stanley L. |
|
2008 |
7 |
2 |
p. 99-104 6 p. |
artikel |